The FDA label also includes warnings about fluid retention (which can cause edema, joint pain, and carpal tunnel syndrome), glucose intolerance or diabetes, elevated IGF-1 levels that require monitoring, increased risk of neoplasms or abnormal cell growth (because Tesamorelin stimulates the release of growth hormone, it is contraindicated in patients with active malignancy), hypersensitivity reactions, and increased mortality risk in critically ill patients (a class-effect warning related to growth hormone-releasing products generally)
Improved Insulin Sensitivity: By improving insulin sensitivity, semaglutide may help with better blood sugar control and potentially reduce insulin resistance, which can contribute to weight loss
Studies show caffeine stimulates thermogenesis and may increase fat oxidation by 311 percent, but this occurs through sympathetic nervous system activation, not GLP-1 pathways
Audio transcript STEVE INSKEEP, HOST: The first milk that mammals produce after giving birth is called colostrum